Transcription factor E2F plays an important role in orchestrating early cell cycle progression through its ability to co-ordinate and integrate the cell cycle with the transcription apparatus. Physiological E2F arises when members of two distinct families of proteins interact as E2F-DP heterodimers, in which the E2F component mediates transcriptional activation and the physical interaction with pocket proteins, such as the tumour suppressor protein pRb. In contrast, a discrete role for the DP subunit has not been defined. We report the identification and characterization of DIP, a novel mammalian protein that can interact with the DP component of E2F. DIP was found to contain a BTB/ POZ domain and shows significant identity with the Drosophila melanogaster germ cell-less gene product. In mammalian cells, DIP is distributed in a speckled pattern at the nuclear envelope region, and can direct certain DP subunits and the associated heterodimeric E2F partner into a similar pattern. DIP-dependent growth arrest is modulated by the expression of DP proteins, and mutant derivatives of DIP that are compromised in cell cycle arrest exhibit reduced binding to the DP subunit. Our study defines a new pathway of growth control that is integrated with the E2F pathway through the DP subunit of the heterodimer.
Introduction
The E2F family of transcription factors plays a critical role in orchestrating early cell cycle progression. In concert with their afferent regulators, which include the retinoblastoma tumour suppressor protein pRb and G 1 cyclin-dependent kinases (cdks), E2F integrates and coordinates early cell cycle events with the transcription of genes required for entry into S phase (Nevins, 1992; Lam and La Thangue, 1994) . Significantly, the pathway responsible for regulating E2F is aberrant in most human tumour cells. For example, the Rb gene frequently suffers inactivating mutations (Weinberg, 1995) , and the cyclin D family, critical regulators of pRb activity, are expressed at high levels in certain tumour 212 © European Molecular Biology Organization cells (Hunter and Pines, 1994; Hall and Peters, 1996) , events that underscore the importance of E2F in growth control.
It is known that physiological E2F arises when a member of two families of proteins, E2F and DP, interact as E2F-DP heterodimers Lam and La Thangue, 1994) . Each E2F component harbours a trans activation domain in the C-terminal region which also physically associates with an appropriate pocket protein, an interaction that impedes transcriptional activation (Flemington et al., 1993; Helin et al., 1993; Zamanian and La Thangue, 1993) . For example, E2F-1 is regulated principally by pRb (Flemington et al., 1993; Helin et al., 1993) , and E2F-4 by p107 and p130 (Beijersbergen et al., 1994; Ginsberg et al., 1994; Sardet et al., 1995; Vairo et al., 1995) . Other levels of control that influence E2F include phosphorylation (Dynlacht et al., 1994; Fagan et al., 1994; Xu et al., 1994; Krek et al., 1995; Altiok et al., 1997; Dynlacht et al., 1997) , protein stabilization (Hateboer et al., 1996; Hofmann et al., 1996; Campanero and Flemington, 1997) and regulated intracellular location (de la Luna et al., 1996; Magae et al., 1996; Allen et al., 1997; Lindeman et al., 1997; Muller et al., 1997) , thus providing additional mechanisms that govern the activity of E2F.
Each E2F protein requires a DP protein as an obligate heterodimeric partner Lam and La Thangue, 1994) . DP-1 is a widespread partner for E2F family members, being present in many cell types (Bandara et al., , 1994 Girling et al., 1993; Wu et al., 1995) , in contrast to, for example, DP-3 which appears to be a less frequent component (Rogers et al., 1996; S.de la Luna and N.B.La Thangue, unpublished data) . In this respect, it is notable that murine DP-3 differs from other members of the E2F and DP families in that the DP-3 RNA undergoes extensive processing due to alternative splicing (Ormondroyd et al., 1995) . Processing events in the 5Ј-untranslated and coding region give rise to spliced variants that are restricted in both cells and tissues (Ormondroyd et al., 1995) . Considering the DP-3 proteins, four distinct isoforms have been identified, referred to as α, β, γ and δ (Ormondroyd et al., 1995) . In addition, a form equivalent to the DP-3δ isoform has been designated human DP-2 (Wu et al., 1995; Zhang and Chellappan, 1995; Rogers et al., 1996) and a form equivalent to murine DP-3α has been described in human cells (Zhang and Chellappan, 1996) .
Previous studies on the properties of the DP-3 proteins have allowed some novel and important regulatory mechanisms in the control of E2F activity to be uncovered. For example, the α and δ isoforms share an alternatively spliced exon, which encodes a sequence of 16 amino acid residues, referred to as the E region, that is absent from the β and γ isoforms (Ormondroyd et al., 1995) ; this amino acid sequence is not present in the DP-1 protein (Ormondroyd et al., 1995) . An analysis of the role of the E region found that it functions as a nuclear localization signal (NLS), specifically in supplying one half of a bipartite NLS (de la Luna et al., 1996) , and hence enabling the incumbent DP protein to undergo nuclear accumulation (de la Luna et al., 1996; Magae et al., 1996) . Importantly, the presence of the E region, and thus nuclear accumulation, endows the DP protein with an ability to promote cell cycle progression when complexed with E2F family members, such as E2F-4 and -5, which lack an intrinsic NLS (Allen et al., 1997; Muller et al., 1997) . In sharp contrast, nuclear accumulation of the E2F heterodimer mediated through pocket protein binding impedes cell cycle progression (Allen et al., 1997) , highlighting the importance of regulated intracellular distribution as a means towards controlling E2F activity.
Studies on the BTB/POZ domain have found that it is an evolutionarily conserved protein-protein interaction domain present in a variety of eukaryotic proteins, many of which have DNA-related functions (Bardwell and Treisman, 1994; Zollman et al., 1994; Albagli et al., 1995) . In Drosophila melanogaster, the BTB/POZ domain protein group is made up of transcription factors which play key roles in a variety of developmental programmes including the onset of metamorphosis, photoreceptor development, specification of abdominal segmentation and pole cell formation in the embryo, muscle recognition by nerve cells and in the development of the limb (Albagli et al., 1995) .
The mammalian group includes proteins involved in transcriptional regulation, with some evidence suggesting additional roles for certain BTB/POZ domain proteins in transcriptional repression (Dhordain et al., 1997b; Hong et al., 1997; David et al., 1998) . Further, they can be important in influencing tumorigenesis as, for example, the gene encoding LAZ3/BCL6 (lymphoma-associated zinc finger 3/B cell lymphomas 6) frequently is altered by chromosomal translocation, small deletions and point mutations in non-Hodgkin lymphomas (Kerckaert et al., 1993; Ye et al., 1993) . Similarly, in a subset of acute promyelocytic leukemia, PLZF (promyelocytic leukemia zinc finger) is fused to the RARα (retinoic acid receptor α) gene (Chen et al., 1993) . Although the contribution of these mutational events to tumorigenesis remains unclear, such studies do nevertheless imply that some BTB/POZ domain proteins have an important role to play in regulating proliferation.
In this study, we report a new mammalian BTB/POZ domain protein and provide evidence that it interacts with the DP component of the E2F heterodimer. The DIP (for DP-interacting protein) protein possesses significant identity to the product of the Drosophila gene germ cellless (Jongens et al., 1992) . In mammalian cells, DIP is located as speckles in the nuclear envelope region and has a dominant influence on the distribution of certain DP proteins by directing them into a similar speckled pattern. DIP is capable of promoting cell cycle arrest, and DIPdependent growth arrest is modulated by the expression of DP proteins. Our study defines a new pathway of growth control that is likely to be integrated with the E2F pathway. 
Results

Isolation of a novel DP-interacting protein
With a view towards understanding the role of the DP subunit of the E2F heterodimer, we reasoned that the Nterminal extension that occurs in the α isoform of DP-3 (Ormondroyd et al., 1995) may function as a protein interaction domain. To explore this idea, we screened for proteins that interact with DP-3 in a yeast two-hybrid screen ( Figure 1A) . From an activation domain-tagged library prepared from 14.5 d.p.c mouse embryos, we identified two recombinants, derived from the same gene, encoding fusion proteins capable of specifically interacting with LexA DBD-DP3N ( Figure 1A , and see Materials and methods). Since the cDNA sequence contained in these recombinants encoded a novel protein, we have tentatively given it the designation DIP, derived from DP-interacting protein. The interaction between LexA DBD-DP3N and DIP was specific; binding was not apparent between DIP and the LexA DNA-binding domain (Lex DBD) or DP-3N and the Gal4 activation domain (GAD; Figure 1B ).
DIP, a novel member of the BTB/POZ domain family of proteins
Using the DIP cDNA, together with combined RACE and cDNA library screening (see Materials and methods), we isolated overlapping clones that allowed us to assemble the complete sequence of murine (m) DIP (Figure 2A ). Conceptual translation of the DIP DNA sequence yielded a 524 residue polypeptide with a predicted mol. wt of 60 kDa. Searching the available DNA and protein sequence databases revealed one other protein with significant similarity to mDIP. Thus, the product of the D.melanogaster germ cell-less gene, GCL, which is required for proper germ cell fate specification during embryogenesis (Jongens et al., 1992 (Jongens et al., , 1994 , had 36% identity and 56% similarity with mDIP ( Figure 2A ). The similarity is distributed throughout both proteins, suggesting that mDIP is a close mammalian homologue of Drosophila GCL. Furthermore, searching the available database of expressed sequence tags has identified several human sequences with Ͼ90% homology to mDIP at the amino acid level, providing further evidence that DIP is highly conserved within mammals.
A notable feature of DIP is the presence, in the Nterminal half of the protein, of a domain previously referred to as BTB/POZ (Figure 2A and B). The BTB/ POZ domain is an~120 residue hydrophobic-rich domain present in a variety of regulatory proteins ( Figure 2B ) that generally fall into two groups according to the sequences present in their C-terminus. One group, which includes the Drosophila kelch (Xue and Cooley, 1993) , mammalian calicin (von Bulow et al., 1995) and several poxvirus proteins (Senkevich et al., 1993) , is characterized by a domain of~50 residues that terminates at a glycine pair repeated several times, which has been shown to be involved in actin binding (Way et al., 1995) . A second group is made up of DNA-binding proteins, most of which contain zinc fingers in the C-terminal region (Albagli et al., 1995) . Like other BTB/POZ domain proteins, the BTB/POZ domain is located in the N-terminal region of DIP. However, none of the protein domains which define the BTB/POZ protein subgroups, namely actin-binding domain or DNA-related domains, are apparent in the Cterminal half of DIP, and thus DIP may constitute another subgroup of BTB/POZ proteins. Other BTB/POZ domain proteins with similar characteristics that fall within this subgroup would include Drosophila GCL (Jongens et al., 1992) , human LZTR-1 (Kurahashi et al., 1995) , rat Cca3 (Hayashi et al., 1997) , Disctyostelum MigA (Escalante et al., 1997) and some Caenorhabditis putative proteins ( Figure 2B ).
Further analysis of the DIP cDNA revealed that the mRNA has an extensive AU-rich 3Ј-untranslated region (UTR), of which~1.2 kb has been sequenced (data not shown), which contains several AREs (adenylate/ uridylate-rich elements), a sequence motif known to regulate the stability of many RNAs that encode protooncogenes, transcription factors and cytokines (Chen and Shyu, 1995) . In addition, two canonical polyadenylation signals (AAUAAA) occur in the 3Ј-UTR separated bỹ 500 bases. Northern analysis of the expression pattern of DIP RNA indicated that it is present at low levels in a wide variety of murine tissues and cell lines as a transcript of~4 kb, although in certain tissues an additional transcript was apparent at 3.5 kb (data not shown) that may arise through the alternative utilization of the two polyadenylation signals in the 3Ј-UTR. In support of this idea, 215 cDNAs with poly(A) tails at both positions were isolated during the library screen (data not shown).
DIP is a nuclear protein concentrated in the nuclear envelope region in which the BTB/POZ domain is necessary for nuclear accumulation To assess the intracellular distribution, we expressed wildtype DIP in mammalian cells and thereafter immunostained. Wild-type DIP accumulated in a striking nuclear pattern that was characterized by discrete speckles and, by confocal microscopy, was located in the nuclear periphery in the region of the nuclear envelope ( Figure 3A ). This pattern was apparent when using different fixation procedures (including formaldehyde, paraformaldehyde or methanol), suggesting that its appearance was not influenced by sample preparation. The speckled distribution of DIP observed here is in general in agreement with other reports on the location of nuclear BTB/POZ proteins (Bardwell and Treisman, 1994; Dong et al., 1996; Dhordain et al., 1997a) , although GCL is the only BTB/POZ domain protein ascribed to a location in the nuclear periphery (Jongens et al., 1994) .
To gain information on the role of the domains in DIP that influence the intracellular distribution, we explored the properties of several derivatives. In the first, DIPΔ46, the staining pattern was very similar to that of wild-type DIP ( Figure 3B ). In the second, DIP-POZ, the entire BTB/ POZ domain was retained in the N-terminal region and efficient nuclear accumulation was apparent, although, in contrast to wild-type, its nuclear distribution was uniform and lacked the discrete speckled appearance characteristic of the wild-type protein [ Figure 3B , compare (i) with (ii)]. In this respect, it is noteworthy that the N-terminal region in DIP-POZ contains two candidate SV40 large T antigenlike NLSs (Kalderon et al., 1984) which may be responsible for the nuclear accumulation (see Figure 2A) . The third DIP derivative analysed, DIPΔPOZ, which contains the C-terminal half of the protein from residue 231 to 524, failed to undergo nuclear accumulation and in many cells retained a cytoplasmic location (Figure 3Biii ). Overall, therefore, these results indicate that DIP is located in the region of the nuclear envelope and further that distinct domains contribute to its intracellular distribution.
DIP contains a dimerization domain
Studies on several other BTB/POZ domain proteins have established that the domain functions in protein-protein interactions, allowing the formation of both homodimers and heterodimers either with other BTB/POZ domain proteins (Bardwell and Treisman, 1994) , or with unrelated proteins (Li et al., 1997) . We were interested in testing the possibility that DIP was capable of dimerization, and for that two versions of DIP were synthesized in vitro; one containing an HA tag, HA-DIP ( Figure 4A , track 1), and another lacking the HA tag, DIPΔ46 ( Figure 4A , track 2). Both proteins were immunoprecipitated efficiently by an antibody which recognizes a C-terminal epitope in DIP ( Figure 4A , tracks 4 and 5). However, when an anti-HA antibody was used in the assay, DIPΔ46 was immunoprecipitated in an HA-DIP-dependent fashion ( Figure 4A , compare tracks 6 and 7), suggesting that both proteins can form a physical complex.
The interaction domain in DIP was explored further using, first, the yeast two-hybrid assay and, secondly, the equivalent mammalian cell-based assay. Thus, wildtype DIP or mutant derivatives were fused to either the LexA DNA-binding domain or the Gal4 activation domain ( Figure 4B ). In yeast, oligomer formation between wild-type DIP was evident, and occurred upon deletion of the N-terminal region up to residue 231 and, furthermore, both bait and prey hybrid proteins
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containing only the C-terminal half of DIP (from residue 231) could interact efficiently ( Figure 4B ). We conclude, therefore, that the presence of the BTB/POZ domain is not required for DIP oligomerization. Rather, the data imply that oligomerization occurs through a domain located in the C-terminal half of DIP. This domain could be defined further as requiring the region from residue 231 to 283 as an interaction was not apparent The in vitro products were immunoprecipitated with an anti-DIP antibody (lanes 4 and 5) or with anti-HA HA11 monoclonal antibody (lanes 6 and 7). Note that DIPΔ46 immunoprecipitated with the anti-HA monoclonal antibody only when HA-DIP was present. (B) DIP homodimerizes in the yeast two-hybrid system: schematic representation of the DIP hybrids used in the two-hybrid experiment, baits being fused to the LexA DNA-binding domain and preys fused to the Gal4 activation domain (GAD). For each bait, β-galactosidase background levels were determined in double transformants with Gal4-GAD alone. Values similar to background levels are given as a '-'. (C) The C-terminal half of DIP is responsible for DIP-DIP interaction in mammalian cells: schematic representation of the fusion proteins used. U2OS cells were transfected with pG5E1b-luc reporter plasmid (1 μg), pG4-DBD (0.5 μg; tracks 1-5), pG4-DIP (0.5 μg; tracks 6-10) or pG4-DIPΔPOZ (0.5 μg; tracks 11-15) as baits. Each bait was co-expressed with VP16-AD alone (pCMV-VP16/NLS: 1.5 μg, tracks 2, 7 and 12; 3 μg, tracks 3, 8 and 13) or DIP fused to VP16-AD (pVP16-DIP: 1.5 μg, tracks 4, 9 and 14; 3 μg, tracks 5, 10 and 15). All plates were co-transfected with pCMV-βgal (0.3 μg) as an internal control. Values are given as the ratio of luciferase to β-galactosidase activities.
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when a hybrid protein DIP 283-524 was used as the prey (data not shown). A similar conclusion was reached when DIP was studied in a mammalian two-hybrid assay where DIP was fused to the Gal4 DNA-binding domain, in G4-DIP, and the VP16 activation domain to DIP in VP16-DIP ( Figure 4C ). Neither VP16 nor VP16-DIP was capable of stimulating the activity of G4-DBD, although significant stimulation occurred when G4-DIP and VP16-DIP were co-expressed ( Figure 4C ), a result consistent with the previous data derived from the yeast two-hybrid assay. Furthermore, in the absence of the BTB/POZ domain (G4-DIPΔPOZ), an interaction was still apparent with VP16-DIP ( Figure 4C ). We conclude that the BTB/POZ domain is not required for DIP oligomerization but, instead, the data suggest that a C-terminal domain is required. In this respect, the BTB/POZ domain in DIP is somewhat unusual as most previously identified BTB/POZ domains function directly in facilitating dimerization.
DIP is a negative regulator of cell cycle progression
Because DIP was isolated by screening with the DP component of the E2F transcription factor, we considered that DIP may regulate cell cycle progression. To address this possibility, we assessed the effect of DIP on the cell cycle using two different assays. In the first, expression vectors for DIP were introduced into human osteosarcoma U2OS cells and its effects on the cell cycle were monitored by flow cytometry. Transfected cells were identified by introducing an expression vector for the cell surface protein CD20 and thereafter staining with an anti-CD20 monoclonal antibody, and the cell cycle kinetics of the transfected population determined by propidium iodide incorporation. The effects of DIP were studied in asynchronous and synchronous populations of U2OS cells, where synchrony had been achieved with nocodazole, a treatment that arrests cell cycle progression in mitosis.
By 36 h post-transfection of U2OS cells with either wild-type DIP or DIPΔ46, a marked increase of~22% in the G 1 population was apparent in this particular experiment, in contrast to the control treatment with the empty vector ( Figure 5A , compare cd20 ϩ /mock with cd20 ϩ / DIPΔ46; and data not shown); comparing a variety of data indicated that on average DIP causes an increase of between 20 and 40% in the G 1 population of transfected cells (data not shown). Similarly, when expression vectors for DIP were introduced into U2OS cells and subsequently treated with nocodazole, an increased G 1 population was still apparent compared with the empty vector-transfected cells where many cells were arrested in the mitotic fraction ( Figure 5A ). As a control and to confirm the effect of DIP, we assessed the CD20-negative population (taken from the cell population transfected with DIP and the control vector) after nocodazole treatment. Both populations were similar in their cell cycle profile, and resembled that for the CD20-positive population transfected with the control vector ( Figure 5A , compare cd20 -/mock with cd20 -/DIP after nocodazole treatment). We conclude that exogenous DIP can promote cell cycle arrest by negatively regulating early cell cycle progression.
As a further indication of the growth-suppressing properties of DIP, we introduced DIP or DIPΔ46 into U2OS , together with 4 μg of pCMVCD20 as described. After removal of the DNA precipitate, cells were incubated in 5% FCS and were harvested 36 h after transfection (first row). Parallel transfections were performed and treated with nocodazole 12 h before harvesting (central row). Transfected cells were identified by staining with a FITC-conjugated anti-CD20 antibody and DNA stained with propidium iodide as described in Materials and methods. For the nocodazole-treated cells, the profiles of non-transfected cells (cd20 -, lower row) are shown as a control for comparison with the CD20 ϩ population of transfected cells. (B) U2OS cells (5ϫ10 5 ) plated in 6 cm dishes were transfected with 5 μg of pCDNA-3 (Vector) or 5 μg of pCMV-DIPΔ46 (DIPΔ46). The selection procedure was performed as described in Materials and methods. Stained plates representative of two different experiments are shown. Note the decrease in the number of colonies when DIP is expressed. cells in a vector that contained an expression cassette for the neomycin resistance gene (see Materials and methods). After transfection, cells were grown under selection in the presence of G418 and the number of resistant colonies determined after 14 days in culture. As expected in the absence of DIP, colony growth was apparent ( Figure 5B ; Vector treatment). In contrast, far fewer colonies were evident when DIP or DIPΔ46 was expressed in the same conditions ( Figure 5B ; DIPΔ46 treatment), a result consistent with the flow cytometry analysis which suggested that DIP possesses the properties of a growth 218 suppressor. The combined conclusions of these two different assays that measured the effects of DIP on proliferation strongly argue that DIP negatively regulates cell cycle progression.
DIP physically interacts with DP-3
Since DIP was isolated by screening in a yeast two-hybrid assay for proteins that could interact with DP, we assessed whether DIP could physically interact with DP proteins. However, assessing the properties of DIP in a variety of extraction procedures indicated that DIP is a highly insoluble protein. For example, in cells transfected with expression vectors encoding wild-type or a variety of DIP derivatives, the DIP proteins were usually exclusively present in the insoluble material harvested from transfected cells ( Figure 6A ). One mutant, ΔPOZ, could be solubilized ( Figure 6A ), presumably because it failed to accumulate in nuclei ( Figure 3B ). These properties of DIP were compared with those of endogenous p53 which, as expected, was soluble ( Figure 6A ). The biochemical insolubility of DIP noted here has been described previously for other BTB/POZ domain proteins (Albagli et al., 1995; Kim et al., 1998) .
As a characterization of DIP could not involve conventional biochemical procedures, we resorted to a variety of alternative approaches. In the first, we attempted to confirm the interaction between DIP and DP-3 using GST pulldown experiments with in vitro translated 35 S-labelled DIP and bacterially expressed GST-DP-3, and thereafter measured the binding efficiency. In these experiments, DIP was retained by both GST-DP-3α and GST-DP-3δ ( Figure 6B , tracks 6 and 8), although with a marginally, but reproducibly greater efficiency with DP-3α ( Figure 6C , tracks 1 and 3). However, when the DIP mutant, DIPΔ46, which lacks 46 amino acid residues from the N-terminus, was used in the assay, the difference in binding efficiency became much more significant ( Figure 6B , compare tracks 5 and 7; and C, tracks 2 and 4). As a control, GST alone was unable to bind to the in vitro translated DIP proteins ( Figure 6B , tracks 3 and 4). We conclude, therefore, that DIP is able to interact with DP-3α and δ isoforms, and that an N-terminal domain in DIP is likely to be involved in discriminating between these two different DP-3 isoforms.
Next, we tested if DP-3 and DIP could associate in mammalian cells. To address this point, we performed two-hybrid assays in mammalian cells with an activation domain-tagged DIP, VP16-DIP ( Figure 7A ). When VP16-DIP was assayed on two different DP baits that contained either the N-terminal 79 amino acid residues of DP-3α, G4-DP3N, or the equivalent region taken from DP-1, G4-DP1N, significant stimulation of activity was apparent with G4-DP3N and not with G4-DP1N ( Figure 7A , compare tracks 9 and 10 with 14 and 15). Similarly, no effect was apparent when VP16-DIP was co-expressed with the Gal4 DNA-binding domain alone ( Figure 7A , tracks 4 and 5). These data suggest that DIP can associate with the N-terminal region of DP-3α in mammalian cells.
A similar assay was performed with hybrid baits in which complete DP-3α and δ sequences were fused to the Gal4 DNA-binding domain. As expected, VP16-DIP enhanced activity in the presence of G4-DP3α, an effect specific for DP-3 since similar stimulation of the DNAbinding domain of Gal4 was not evident ( Figure 7B , compare tracks 4 and 5 with 9 and 10). Furthermore, and consistent with the earlier data ( Figure 6B ), co-expression of VP16-DIP with G4-DP3δ also resulted in increased activity ( Figure 7B , compare tracks 4 and 5 with 14 and 15). Thus, although DIP can interact with the N-terminal region of DP-3α, it is likely that an additional part of DP-3 within the sequence shared by the α and δ isoforms can also interact with DIP.
The region in DIP that is responsible for the common interaction with the α and δ isoforms was next considered. In the mammalian two-hybrid assay, a hybrid protein in which the BTB/POZ domain was fused to the VP-16 activation domain, in VP16-POZ, enhanced the activity 219 of both G4-DP3α and G4-DP3δ ( Figure 7C , compare tracks 4 and 5 with 9, 10, 14 and 15). These data suggest that the DIP BTB/POZ domain is likely to be a region responsible for the interaction with DP-3α and δ.
DIP directs DP proteins and the E2F heterodimer into the nuclear speckles Finally, since DIP showed a characteristic staining pattern when exogenously expressed, we analysed whether co-expression of DIP with DP-3 could direct DP-3 into the DIP-dependent nuclear speckles. Such a result would be compatible with the idea of a dominant influence of DIP on DP-3, most likely through a direct interaction between both proteins. These co-localization studies were performed with DIPΔ46 because this mutant, although fully competent to bind DP-3, was able to discriminate between DP-3α and δ isoforms in the biochemical experiments described earlier ( Figure 6B and C) and gave a nuclear localization pattern similar to wild-type DIP (Figure 3) . Thus, the α isoform of DP-3 was co-expressed with DIPΔ46 in a variety of mammalian cell types. In U2OS cells, DP-3α efficiently accumulated in nuclei ( Figure 8A ), consistent with our previous results (de la Luna et al., 1996) , to give a nuclear diffuse staining pattern. When DP-3α and DIPΔ46 were co-expressed, in striking contrast to the distribution in the absence of DIP, DP-3α became concentrated in the nuclear speckles, resulting in an almost complete coincidence between DIP and DP-3α (Figure 8 , compare e and f).
We assessed the specificity of the co-localization by determining if DP-3δ, which lacks the α-specific interaction domain, was subject to a similar influence. In cells co-expressing DIPΔ46 and DP-3δ, the nuclear distribution of DIPΔ46 retained its characteristic nuclear speckles and, in the vast majority of cells, DP-3δ failed to co-localize with the DIPΔ46 speckles (Figure 8 , compare g and h); very occasionally, however, DP-3δ was seen to co-localize very faintly in some of the expressing cells, a result in agreement with the weak DP3δ-DIPΔ46 interaction apparent from the in vitro binding data ( Figure 6 ). These data support the idea that DP-3 is directed to the nuclear 3 and 4) , GST-DP-3α (lanes 5 and 6) or GST-DP-3δ (lanes 7 and 8) immobilized on glutathioneagarose beads, and incubated as described in Materials and methods. Bound proteins were detected by SDS-PAGE followed by autoradiography. (C) Summary of the amount of translated protein retained in the pull-down experiment: Tracks 1 and 2 represent the amount of DIP and DIPΔ46 proteins retained in GST-DP-3α beads, respectively; tracks 3 and 4 represent the amount of DIP and DIPΔ46 proteins retained in GST-DP-3δ beads, respectively. The amount of bound labelled protein was calculated by densitometer scanning of the autoradiographs. The values are shown as the percentage of input protein.
speckles in a DIP-dependent fashion, a process which is likely to be caused by the physical association between the two proteins.
We next examined whether the association between DIP and DP-3α was compatible with formation of the DP-3-E2F heterodimer by assessing if an associated E2F partner could likewise be directed to the DIP-dependent nuclear speckles. Consistent with our previous studies, coexpresssion of DP-3α with E2F-5, which is predominantly cytoplasmic in the absence of a nuclear targeting subunit such as DP-3α (Allen et al., 1997) , caused the nuclear accumulation of E2F-5 (Figure 9, compare b and d) . However co-expression of DIP together with DP-3α and E2F-5 caused E2F-5 to become localized in a pattern of 220 nuclear speckles that was co-incident with the distribution of DP-3α (Figure 9 , compare e and f). Therefore, DIP can direct the E2F heterodimer into the nuclear speckles.
DIP can regulate E2F site-dependent transcription
That DIP can interact with DP proteins prompted us to examine the possibility that this interaction reflected the ability of DIP to regulate E2F site-dependent transcription. To investigate this idea, we studied the effect of co-expressing DIP with either E2F-5 or E2F-1 together with DP-3 on the transcriptional activity of the cyclin E promoter, a cellular promoter that is known to be E2F responsive (Botz et al., 1996; Geng et al., 1996) . In the presence of E2F-5 and either DP-3α or DP-3δ, clear activation of the cyclin E promoter was apparent ( Figure 10A , tracks 5 and 6). Although the co-operation between E2F and DP components was striking, there were insignificant differences between the transcriptional effects of DP-3α and DP-3δ ( Figure 10A ), a result consistent with previous studies (Ormondroyd et al., 1995) . However, the co-expression of DIP with either of the E2F-5-DP-3 heterodimers caused a considerable reduction in the level of E2F site-dependent transcription ( Figure 10A , compare tracks 5 and 6 with 11 and 12). The transcriptional activity was usually diminished up to a level approaching 50%, and increased amounts of DIP failed to cause a greater reduction in activity (data not shown).
Similar results were apparent when the effects of DIP were assessed on the E2F-1-DP-3 heterodimer. In this experiment, we examined the effect of DIP on an E2F-1 mutant, E2F-1Y, which fails to bind to pRb (Helin et al., 1993) , and therefore ruled out any indirect effects that DIP may have on the activity of pRb and its interaction with E2F-1. As observed previously , E2F-1 could stimulate E2F site-dependent transcription in Fig. 7 . DIP can interact with DP-3 isoforms. (A) DIP can interact specifically with the DP-3α N-terminal region: schematic representation of the fusion proteins used in the mammalian twohybrid assay. U2OS cells were transfected with pG5E1b-luc reporter plasmid (1 μg), pG4-DBD (0.5 μg; tracks 1-5), pG4-DP3N (0.5 μg; tracks 6-10) or pG4-DP1N (0.5 μg; tracks 11-15) as baits. Each bait was co-expressed with VP16-AD alone (pCMV-VP16/NLS: 1.5 μg, tracks 2, 7 and 12; 3 μg, tracks 3, 8 and 13) or DIP fused to VP16-AD (pVP16-DIP: 1.5 μg, tracks 4, 9 and 14; 3 μg, tracks 5, 10 and 15). All plates were co-transfected with pCMV-βgal (0.3 μg) as internal control. Values are given as the ratio of luciferase to β-galactosidase activities. (B) DIP can interact with DP-3 isoforms: schematic representation of the fusion proteins used in the mammalian two-hybrid assay in (B) and (C). U2OS cells were transfected with pG5E1b-luc reporter plasmid (1 μg), pG4-DBD (0.5 μg; tracks 1-5), pDP3α-G4DBD (0.5 μg; tracks 6-10) or pDP3δ-G4DBD (0.5 μg; tracks 11-15) as baits. Each bait was co-expressed with VP16-AD alone (pCMV-VP16/NLS: 1.5 μg, tracks 2, 7 and 12; 3 μg, tracks 3, 8 and 13) or DIP fused to VP16-AD (pVP16-DIP: 1.5 μg, tracks 4, 9 and 14; 3 μg, tracks 5, 10 and 15). All plates were co-transfected with pCMV-βgal (0.3 μg) as internal control. Values are given as the ratio of luciferase to β-galactosidase activities. (C) The N-terminal half of DIP protein is responsible for the DIP-DP-3 interaction: U2OS cells were transfected with pG5E1b-luc reporter plasmid (1 μg), pG4-DBD (0.5 μg; tracks 1-5), pDP3α-G4DBD (0.5 μg; tracks 6-10) or pDP3δ-G4DBD (0.5 μg; tracks 11-15) as baits. Each bait was co-expressed with VP16-AD alone (pCMV-VP16/NLS: 1.5 μg, tracks 2, 7 and 12; 3 μg, tracks 3, 8 and 13) or DIP 21-232 fused to VP16-AD (pVP16-DIP/ POZ: 1.5 μg, tracks 4, 9 and 14; 3 μg, tracks 5, 10 and 15). All plates were co-transfected with pCMV-βgal (0.3 μg) as internal control. Values are given as the ratio of luciferase to β-galactosidase activities. Fig. 8 . DIP can translocate DP-3 into nuclear foci. U2OS cells were transfected with 3 μg of pSV-DP3α (a, b, e and f ) or 3 μg of pSV-DP3δ (c, d, g and h) and pCDNA-3 (upper row) or pCMV-DIPΔ46 (bottom row). The intracellular distribution of the DP-3 isoforms and the DIP protein was determined by immunofluorescence with a rabbit polyclonal anti-DP3 antibody (a, c, e and g) and an anti-T7 monoclonal antibody (b, d, f and h). The intracellular distribution of exogenous DP-3α (a) and DP-3δ (c), exogenous DP-3α (e) and DIPΔ46 (f) in cells expressing both proteins, and of DP-3δ (g) and DIPΔ46 (h) in cells expressing both proteins is shown. Note that when DP-3 isoforms are co-expressed with DIPΔ46 only DP-3α co-localized with DIP nuclear foci.
the absence of a DP partner, although the level of activity was augmented upon co-expression of a DP partner ( Figure 10B , compare tracks 2 with 5 and 6). In these conditions, the co-expression of DIP caused a reduction in the activity of the E2F-1Y-DP-3 heterodimer ( Figure 10B , compare tracks 5 and 6 with 11 and 12) whilst having little apparent effect on the activity of E2F-1Y in the absence of a co-expressed DP partner ( Figure 10B , compare tracks 2 with 8). Furthermore, in a similar fashion to the effect of DIP on the E2F-5 heterodimer ( Figure 10A ), DIP failed to cause the complete inactivation of the E2F-1-DP-3 heterodimer, but caused an~50% reduction in the transcriptional stimulation that resulted from expression of the DP component ( Figure 10B , compare track 2 with 5 and 6, and 11 and 12). Overall, therefore, these results show that DIP can diminish the activity of E2F sitedependent transcription.
DIP is a potent transcriptional repressor in mammalian cells
Based on the previous data, we wished to determine whether DIP possesses an intrinsic capacity to repress transcription. For this purpose, the ability of DIP fused to the Gal4 DNA-binding domain to affect transcription was tested on pSV-GAL-tk, a reporter construct which contains a single Gal4-binding site between the SV40 enhancer and the herpes simplex minimal thymidine kinase promoter ( Figure 11A ). Strikingly, G4-DIP repressed transcription from pSV-GAL-tk, an effect that was specific for DNA-bound DIP since repression was not evident either with the Gal4 DNA-binding domain alone, or when DIP was expressed without the Gal4 DNA-binding domain when a marginal increase in transcriptional activity was usually apparent ( Figure 11B , compare track 3 with tracks 1 and 4). The level of 221 repression caused by G4-DIP was similar to the effect of G4-p107 ( Figure 11B , compare tracks 2 and 3). Thus, we conclude that DIP is endowed with an intrinsic ability to repress transcription in mammalian cells but, in order to do so, it needs to be targeted to the promoter context.
DP proteins modulate DIP-dependent growth arrest
The introduction of DP-3α into U20S cells caused an induction of the G 2 /M phase population (Figure 12 , tracks 4-6), suggesting that the α isoform could stimulate cell cycle progression. This effect was augmented by coexpressing E2F-5 with DP-3α (Figure 12 , compare tracks 4-6 with 10-12), although alone E2F-5 had little effect (Figure 12 , tracks 7-9).
We co-expressed the α isoform with DIP to determine if DIP could influence the effects of DP-3 on cell cycle progression or vice versa. The co-expression of DP-3α with DIP caused a marked difference in cell cycle profile. Specifically, the induction of the G 1 population by DIP was reduced markedly by co-expressing DP-3α (Figure 12 , compare tracks 1-3 with 13-15) and the stimulation of cell cycle progression caused by DP-3α alone was compromised, a conclusion particularly evident from studying the size of the G 2 /M population (Figure 12 , compare track 6 with 15). Under these conditions, the effect of co-expressing E2F-5 was considerable. Specifically, DP-3α and E2F-5 together with DIP further reduced the size of the G 1 population and concomitantly enhanced the S and G 2 /M phase population (Figure 12 , compare tracks 13-15 with 16-18). Overall, these results argue that cell cycle arrest caused by DIP, namely the increased G 1 population, is modulated by coexpressing DP-3. 
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Multiple domains in DIP influence negative growth control and the regulation of E2F activity We sought to gather genetic evidence that DIP can influence cell cycle progression through a modulation of E2F activity and, to pursue this question, we generated a panel of DIP mutant derivatives that were truncated at the N-or C-terminal regions, or possessed internal deletions (summarized in Figures 13A and 14A) . We examined the effects of these mutants on cell cycle progression and thereafter correlated their effects with the regulation of E2F site-dependent transcription.
Since a striking effect of DIP was on the size of the G 1 population, we examined first the G 1 effect of the DIP derivatives and compared these effects with wild-type DIP. For example, DIPΔPOZ, which lacks the N-terminal half of DIP including the BTB/POZ domain ( Figure 13A) , was compromised in G 1 arrest and, likewise, DIP 46-232 , which encompasses the BTB/POZ domain, also showed reduced cell cycle arrest ( Figure 12B ). An inspection of the DP-3-binding properties of ΔPOZ and DIP 46-232 indicated a significant reduction in binding relative to wild-type DIP ( Figure 13C , compare lanes 1 and 2, 3 and 4, and 5 and 6). Furthermore, and consistent with this result, neither DIP derivative had a significant effect on E2F site-dependent transcription, in contrast to DIP 1-425 which behaved in a similar fashion to wild-type DIP ( Figure 14D ). These data suggest that the properties of DIP are influenced by distinct domains. They also support the importance of DP-3 as a target in DIP-dependent growth arrest.
We progressed on to analyse the properties of two additional mutant derivatives of DIP, namely DIP Δ232-285 and DIP Δ144-189 ( Figure 14A ). The effect of each mutant on the G 1 population was quite different, as DIP Δ232-285 caused a reduced cell cycle arrest whereas, in contrast, DIP Δ144-189 retained wild-type activity ( Figure 14B ). Furthermore, the ability to regulate cell cycle progression correlated with the DP-3-binding activity of the two DIP mutants, as DIP Δ232-285 had reduced binding activity whereas DIP Δ144-189 bound DP-3 as efficiently as wildtype DIP ( Figure 14C , compare lanes 4, 5, 6, 7 and 9). (Bremner et al., 1995) . (B) U2OS cells were co-transfected with 2 μg of reporter pSV-Gal-tk and 2 μg of the following plasmids: pG4-DBD (track 1), pGAL107Δ133 (track 2), pG4-DIP (track 3) and pCMV-DIPΔ46 (track 4). pCMV-βgal (0.3 μg) was included in all transfections for luciferase normalization. The value obtained with reporter alone was given an arbitrary assignment of 100.
Finally, we investigated the properties of DIP Δ282-285 on the regulation of E2F site-dependent transcription and compared its characterisitcs with those of wild-type DIP. In contrast to the inactivation of E2F-dependent transcription that resulted from co-expression of wildtype DIP, DIP Δ232-285 failed to alter significantly the transcriptional activity of the cyclin E promoter driven by the DP-3-E2F-5 heterodimer ( Figure 14D, compares  lanes 2, 3 and 4) . These data show that there is a correlation between the ability of DIP to cause cell cycle arrest, bind to DP-3 and inactivate E2F sitedependent transcription, and are consistent with the idea that DIP Δ232-285 fails to affect cell cycle progression because its DP-3-binding activity is compromised.
Discussion
DIP, a new BTB/POZ domain protein
It is significant that DIP possesses a BTB/POZ domain, an interaction domain found in a growing number of 223 Fig. 12 . Effects of DIP and DP proteins on cell cycle progression. U20S cells were transfected with expression vectors for DIP (16 μg), DP-3α (10 μg) or E2F-5 (10 μg) as indicated, together with the CD20 expression vector (4 μg). Backbone expression vectors were added to normalize the amounts of DNA in each transfection. Transfected cells were identified by staining with an FITC-conjugated anti-CD20 antiserum and DNA stained with propidium iodide as described in Materials and methods. Cells transfected with CD20 and backbone expression plasmids exhibited a cell cycle profile with~50% cells in the G 1 phase, 20% in the S phase and 30% in the G 2 /M phase of the cell cycle. The results are presented as the percentage change of cells in each phase of the cell cycle relative to CD20-expressing cells transfected with empty expression plasmids. eukaryotic proteins, some of which are known to be able to regulate transcription and growth (Bardwell and Treisman, 1994; Albagli et al., 1995) . For example, the oncoproteins LAZ3/BCL6 and PLZF, the genes for which are rearranged recurrently in hematological malignancy (Chen et al., 1993; Kerckaert et al., 1993) , contain BTB/ POZ domains together with a cluster of zinc fingers in their C-terminal domain. Three other human members have been reported as candidate tumour suppressor genes. The HIC-1 gene is underexpressed in tumour cells due to hypermethylation (Makos Wales et al., 1995) . The Miz-1 gene, cloned by means of its interaction with Myc, has a potent arrest function (Peukert et al., 1997) , and the APM-1 gene is co-transcribed aberrantly with HPV68 E6 and E7 genes in a cervical carcinoma cell line (Reuter et al., 1998) . Other family members, such as GAGA and Mod (mdg 4), influence transcription but through mechanisms that are likely to be related to the chromatin state (Gerasimova et al., 1995; Tsukiyama and Wu, 1995) . Further, several BTB/POZ domain-containing transcription factors have been shown to act as transcriptional repressors (Brown et al., 1991; Chang et al., 1996; Dong et al., 1996) , and the BTB/POZ domain has been assigned an important role in mediating this repressive effect. For example, recent results have defined a functional interaction between the BTB/POZ domain proteins LAZ3/ BCL6 and PLZF, and the transcriptional repressors NCoR/ SMRT (Dhordain et al., 1997b; Hong et al., 1997; David et al., 1998) , thus connecting BTB/POZ-dependent repression with shared factors used by other types of transcriptional repressors.
In higher eukaryotic cells, the nuclear lamina and heterochromatin are adjacent to the inner nuclear envelope, and it is therefore possible that contact points can be established between the nuclear membrane and heterochromatin (Blobel, 1985) . In this sense, HP1 (heterochromatin 2) , ΔPOZ (lanes 3 and 4) and DIP 46-232 (lanes 5 and 6) in the presence of [ 35 S]methionine. Translated proteins were mixed with either 1 μg of GST-DP-3α (lanes 1, 3 and 5) or GST (lanes 2, 4 and 6) immobilized on glutathione-agarose beads, and treated as described. Note that in contrast to the binding of wild-type DIP, the ΔPOZ and DIP 46-232 proteins bind much less efficiently to DP-3. (D) The E2F reporter pCyclinE-luc (1 μg) together with expression vectors for E2F-5 (0.5 μg), DP-3α (0.5 μg), DP-3δ (0.5 μg) or the indicated DIP derivatives (2.0 μg) were transfected into U20S cells and assayed as described for Figure 10. protein 1), which is likely to be a structural adaptor with a role in assembling macromolecular complexes in chromatin, has been shown to interact with the lamin B receptor, an integral protein of the inner nuclear envelope (Ye and Worman, 1996) . Furthermore, in yeast, positioning chromatin in the perinuclear region can facilitate transcriptional silencing (Andrulis et al., 1998) . Perhaps, given the implied role of some BTB/POZ domain proteins in chromatin control (Gerasimova et al., 1995; Tsukiyama and Wu, 1995) and the established interaction between some BTB/POZ domain proteins and co-repressors which act through histone modification (Dhordain et al., 1997b; Hong et al., 1997; David et al., 1998) , DIP might accumulate in nuclear compartments that house a certain type of chromatin structure. 7) and DIP Δ144-189 (lanes 8 and 9), was assessed as described in Figure 13 ; lanes 1, 2 and 3 show the input in vitro translated proteins. Translated proteins were mixed with either GST-DP-3 (lanes 5, 7 and 9) or GST (lanes 4, 6 and 8) and treated as described. Note that DIP Δ232-285 has reduced binding activity whereas DIP Δ144-189 has similar activity to wild-type DIP. (D) The E2F reporter pCyclin E-luc (1 μg) together with expression vectors for E2F-5 (0.5 μg), DP-3δ (0.5 μg), or the indicated DIP derivatives (2.0 μg) were transfected into U20S cells and analysed as described for Figure 10 .
DIP is related to Drosophila GCL
The D.melanogaster BTB/POZ protein GCL (Jongens et al., 1992) has the greatest identity with DIP, showing an overall level of 36%. The mechanism of action of GCL is not clear, although it is known to be necessary for germ cells to complete their differentiation programme (Jongens et al., 1992 (Jongens et al., , 1994 . However, two interesting and relevant properties of Drosophila GCL have been described previously. First, it is known that GCL is a nuclear protein localized in the proximity of nuclear pores of the germ cell precursors (Jongens et al., 1994) and secondly, the overexpression of GCL in embryos causes a delay in mitosis during the pole bud nuclear divisions at the syncytial blastoderm stage (Jongens et al., 1994) , suggesting a role for GCL in regulating cell cycle control.
As yet, we do not know whether the conservation between GCL and DIP reflects a common function, although the high level of DIP RNA during murine spermatogenesis is consistent with a role for DIP in germ cell specification (S.de la Luna and N.B.La Thangue, unpublished data). However, other properties of DIP, such as the low but widespread expression of DIP RNA in tumour cell lines, together with its effects on cell proliferation imply perhaps a more widespread role for DIP than previously assigned to GCL. Thus, whilst we find the relationship between DIP and GCL to be provocative and interesting, it is possible that DIP plays a more general physiological role.
DIP is integrated with the E2F pathway
It is clear from the large body of evidence that already exists that E2F plays an instrumental role in co-ordinating and integrating early cell cycle progression Lam and La Thangue, 1994) . E2F-binding sites, which occur in the promoters of a wide variety of genes required for proliferation, can function as either positive or negative regulators of transcription activity (Muller, 1995) . Indeed, the physical association of pRb with E2F, in which pRb conceals the trans activation domain (Flemington et al., 1993; Helin et al., 1993) , combined with the intrinsic capacity of pRb to repress transcription (Bremner et al., 1995) , are features that are likely to be critical in the control of E2F activity.
Our study has identified DIP as a regulatory protein that can influence E2F activity. However, in contrast to the pRb family, where the association with E2F is direct and occurs through the C-terminal region in each E2F family member (Flemington et al., 1993; Helin et al., 1993) , the interaction of DIP depends upon the DP family member. This view is supported by a variety of data presented in this study, including the isolation of DIP with a DP 'bait' in the two-hybrid screen, the in vitro physical interaction between DIP and DP proteins, the mammalian two-hybrid assays, the DP-dependent regulation of E2F activity by DIP and the DIP-directed intracellular localization of E2F. Moreover, the analysis of mutant derivatives of DIP and their interaction with DP proteins support a role for this interaction in mediating the functional effects of DIP on cell cycle progression. Overall, therefore, these results suggest that the activity of DIP is integrated with the E2F pathway.
However, a model that explains the physiological relevance of DIP in the regulation of E2F activity and cell cycle control has to encompass the results from the analysis of the mutant DIP derivatives, which although supporting the importance of the DP subunit do not rule out the possibility that multiple domains in DIP may influence its growth-regulating capacity. One possible model predicts that the growth-regulating properties of DIP are mediated through the integration of DIP activity with multiple pathways (Figure 15) , and that the interplay between DIP and the E2F pathway presented in this study represents one such pathway. Such an idea is compatible with previous studies which have defined the BTB/POZ domain as an interface capable of protein-protein interactions with either other BTB/POZ domains or unrelated proteins (Bardwell and Triesman, 1994; Li et al., 1997) , and the results from this study showing that DP proteins interact with a domain in DIP other than the BTB/ POZ domain.
Nevertheless, our study has defined a new pathway of growth control that is integrated with E2F and mediated through the novel BTB/POZ domain DIP, and allows a 225 Fig. 15 . Model for DIP-dependent growth control. It is envisaged that the effects of DIP on cell cycle progression are exerted through an interplay not only with the E2F pathway, mediated through an association with DP proteins, but with at least one additional as yet unidentified pathway of control.
number of significant and novel conclusions to be reached on the role of the DP subunit in the E2F heterodimer. Moreover, the negative growth-regulating properties of DIP are analogous to those possessed by pRb, the gene for which is mutated with high frequency in a variety of human malignancies. It will be interesting to establish whether the gene for DIP similarly suffers inactivating mutations in tumour cells and the influence of such events on E2F activity.
Materials and methods
Yeast two-hybrid screening Yeast two-hybrid screening was performed using as a bait the N-terminal 79 amino acids from mouse DP-3α fused to the DNA-binding domain of LexA in pLex(His) (Buck et al., 1995) . The Saccharomyces cerevisiae strain CTY-10d, which carries an integrated lacZ reporter gene under the control of a LexA-responsive promoter, was transformed with the DP-3α bait and a mouse 14.5 d.p.c. embryonic cDNA library fused to the Gal4 activation domain (Chevray and Nathans, 1992) , and double transformants were plated in the appropriate selective medium. About 2ϫ10 6 double transformants were screened by filter assay for the induction of β-galactosidase according to standard procedures. Two positives were obtained, and plasmids containing the prey sequences were rescued and checked by back transformation with the bait into yeast. In order to obtain a full-length cDNA clone, an F9EC cDNA library was screened by hybridization with cDNA fragments and several clones isolated and sequenced. 5Ј End sequences were obtained using RACE on mouse testis RNA (Clontech) and gene-specific oligonucleotides.
Sequences of the cDNA clones were determined in both strands manually (Sequenase, Amersham) or with an ABI dye terminator cycle sequencing-ready reaction kit (Perkin Elmer) and an automated DNA sequence analyser. Sequences were assembled into contigs with the Seqman programme from the DNAStar package (DNASTAR, Inc.). Database searches and sequence comparisons were done using the following programs provided by the National Center for Biotechnology Information: BLAST (Altschul et al., 1990) , gapped BLAST and PSI-BLAST (Altschul et al., 1997) .
For analysing protein-protein interactions in yeast, CTY-10d cells were transformed with various combinations of plasmids expressing LexA DNA-binding domain (DBD)-tagged and Gal4 activation domain (GAD)-tagged molecules. Transformants were plated in the appropriate selective media and β-galactosidase activity determined for at least three independent colonies as described (Ormondroyd et al., 1995) .
Plasmids
Yeast two-hybrid assay. pGAD, pLex(His), pLex-DP3α and pLex-DP3δ have already been described (Buck et al., 1995; Ormondroyd et al., 1995) . LexA-DBD derivatives were constructed by cloning the appropriate DNA segments from DP-3 genes and DIP cDNA into pLex(His). For generating the Gal4-AD derivatives, plasmid pACT-II (Clontech) was used as backbone vector.
Mammalian two-hybrid assay. pG4-DBD was constructed by cloning a HindIII-EcoRI fragment from pSG424 (Sadowski and Ptashne, 1989) containing the Gal4 DNA-binding domain (amino acids 1-147) into pCDNA-3 (Invitrogen). pG4DP-3N and pG4DP-1N were constructed by fusing the nucleotide sequence corresponding to the first 79 amino acids of mouse DP-3 and DP-1 in-frame with the Gal4 DNA-binding domain in pG4-DBD. pG4-DIP was made by insertion of a SalI-EcoRV fragment coding amino acids 8-524 of DIP into pG4-DBD. pDP3α-G4DBD and pDP3δ-G4DBD are C-terminal fusion proteins with the G4-DBD and were made by inserting a PCR product containing G4-DBD (amino acids 1-147) into a BamHI site of pSV-DP3α and pSV-DP3δ (de la Luna et al., 1996) . Two DIP fragments encoding amino acids 23-524 and 21-232 were fused downstream of the VP16 activation domain in pCMV-VP16/NLS (N.Shikama and N.B.La Thangue, submitted) to generate pVP16-DIP and pVP16-POZ. Reporter vectors pG5E1b-luc and pSV-Gal-tk-luc have already been described (Lee et al., 1998) Mammalian expression vectors. the following expression vectors have been already described: pSV-DP3α and pSV-DP3δ (de la Luna et al., 1996) , pCMV-HAE2F5 (Allen et al., 1997) , pCMV-βgal , pGal-107Δ133 (Bremner et al., 1995) , pCyclinEluc (Botz et al., 1996) and pSG5 (Green et al., 1988) . To construct pCMV-DIP and pCMV-HADIP, full-length DIP was cloned into pCDNA-3 and pCMV-HA1 (Lee et al., 1998) , respectively. For generating DIP mutant tagged expression vectors, first the sequence for a T7 epitope was cloned into pCDNA-3 to produce N-terminus T7-tagged versions. The plasmids were used as a backbone vector for inserting a NotIEcoRV fragment (amino acids 47-534), a NotI-XhoI fragment (amino acids 47-232) and an XhoI-EcoRV fragment (amino acids 231-534) from DIP full-length cDNA to generate pCMV-DIPΔ46, pCMV-DIP/ POZ and pCMVDIPΔPOZ, respectively. All DIP derivative mutants were made using pCMV-DIP as the original plasmid and by cutting, filling in and ligating compatible endonuclease restriction sites within the DIP sequence to generate a continuous reading frame. DIP1-425, ClaI; DIP Δ232-285 , XhoI-PvuII; DIP Δ144-189 , SspI-SphI.
Transfections
Human osteosarcoma U2OS cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal calf serum (FCS). Transfections were carried out using the calcium phosphate precipitation method. Cells were plated out 24 h before transfection at 1ϫ10 5 per 6 cm dish (two-hybrid assays, immunostaining and transcription assays) or 1ϫ10 6 per 10 cm dish (flow cytometric analysis), washed and refed after 16 h in the presence of the DNA precipitate, and harvested and processed at a final time of 36 h post-transfection. DNA amounts were kept constant by adding pCDNA-3 or pSG5 when required. pCMV-β-galactosidase was used as an internal standard for transfections. Luciferase and β-galactosidase activities were measured in duplicate plates for each point.
For the G418 selection, cells on 6 cm dishes were transfected as described above. After washing, cells were trypsinized and plated at 1:10 dilution in 10 cm dishes. Next day, antibiotic selection was applied starting at 500 μg/ml G418 (Sigma). Cells were refed with medium with fresh antibiotic every 3-4 days until colonies were apparent (~3 weeks). Cells were washed with phosphate-buffered saline (PBS), fixed with 10% formaldehyde and stained with 1% crystal violet (w/v) in 1% formaldehyde.
To arrest cells at the G 2 /M phase of the cell cycle, cells transfected as described above were treated with 40 ng/ml nocodazole in dimethylsulfoxide (DMSO) for 12 h prior to harvesting. Control cells were treated with DMSO alone.
Protein expression was checked for DIP and its derivatives by Western blotting using total cell extracts. For that, transfected cells were harvested in PBS, pelleted and resuspended in 1ϫ SDS sample buffer. Proteins were electrophoresed in 15% SDS-polyacrylamide gels, transferred to Immobilon-P membranes (Millipore) and bands detected using ECL detection (Calbiochem). A rabbit polyclonal serum raised against a DIPspecific peptide was used at a 1:500 dilution, and peroxidase-conjugated anti-rabbit antibody (Amersham) was used as secondary antibody.
For the solubility assay, transfected cells were harvested and resuspended in lysis buffer [50 mM Tris-HCl pH 8.0, 400 mM KCl, 1 mM EDTA, 1 mM dithiothreitol (DTT), 1% NP-40 and a protease inhibitor cocktail from Boehringer Manheim]. After being kept on ice for 30 min to allow solubilization, extracts were centrifuged at 5000 r.p.m. for 5 min. Supernatants from this step were considered as the soluble 226 fraction (S fraction). The insoluble material contained in the pellets (I fraction) was resuspended in SDS sample buffer. Proteins were detected as described above using the anti-DIP polyclonal antibody and the anti-p53 monoclonal antibody DO1 (Santa Cruz).
Immunostaining
Cells grown on coverslips were washed in PBS and treated at room temperature as follows with PBS washings after each step: fixation in 4% paraformaldehyde in PBS for 15 min, permeabilization in 1% Triton X-100 in PBS for 10 min, blocking in 5% FCS in PBS for 15 min, incubation with primary antibody in 1% FCS in PBS for 30 min and incubation with secondary antibodies in 10% FCS in PBS for 30 min. Coverslips were mounted in Citifluor (Citifluor Ltd), and cells photographed with an Olympus B ϫ60 or confocal microscope.
The following primary antibodies were used: anti-HA monoclonal antibody HA11 (1:1000, Babco), anti-T7 tag monoclonal antibody (1:10 000, Novagen), anti-DIP polyclonal (1:200) and anti-DP3 rabbit polyclonal antibody (de la Luna et al., 1996) . The secondary antibodies goat fluorescein isothiocyanate (FITC)-conjugated anti-rabbit and goat tetramethylrhodamine isothiocyanate (TRITC)-conjugated anti-mouse (Southern Biotechnology Associates, Inc.) were used at a 1:200 dilution.
Flow cytometry
DNA transfections included 4 μg of pCMVcd20 and 16 μg of the plasmid to assay. After transfection, cells were detached by treatment with cell dissociation solution (Sigma). Approximately 1ϫ10 6 cells were incubated at 4°C with 20 μl of the FITC-conjugated anti-cd20 antibody (Becton Dickinson) for 30 min. Cells were washed twice with PBS and fixed in 50% ethanol in PBS at 4°C for at least 1 h. Fixed cells were washed and resuspended in 50 μg/ml propidium iodide containing 125 U/ ml RNase A. Analysis was done on a Becton Dickinson fluorescenceactivated cell sorter using the FACscan software package. About 1ϫ10 4 events were collected for each sample.
In vitro protein interaction
The 35 S-labelled proteins were synthesized in vitro using the Promega TNT kit and T7 RNA polymerase in the presence of [ 35 S]methionine.
For immunoprecipitations, in vitro translated products were diluted in 200 μl of TNN buffer [50 mM Tris-HCl pH 7.4, 120 mM NaCl, 0.5% NP-40, 1 mM DTT, 1 mM phenylmethylsulfonyl fluoride (PMSF) and 20 mg/ml aprotinin] and incubated with 20 μl of a 50% slurry (w/v) of protein G-agarose beads pre-incubated with HA11 monoclonal antibody and washed in TNN. After an incubation of 1 h at 4°C, the beads were washed four times with TNN buffer and the proteins released in SDS sample buffer and detected by SDS-PAGE followed by autoradiography.
For interactions with GST proteins, in vitro translated products were diluted in 200 μl of incubation buffer (50 mM Tris pH 8, 100 mM NaCl, 0.5% NP-40, 1 mM DTT, 0.5 mM EDTA, 0.2 mM EGTA and 1 mM PMSF). Approximately 1 μg of GST fusion proteins or GST protein alone, purified from bacteria as described in Ormondroyd et al. (1995) , was added in a total of 20 μl of glutathione-agarose beads and the proteins incubated at 4°C for 5 h. The beads were washed four times in incubation buffer and bound proteins detected by SDS-PAGE followed by autoradiography. Autoradiographs were quantitated by densitometry scanning using a Bio-Rad GS670 Imaging Densitometer.
